Companies /Real Estate
Sabra Healthcare REIT Inc
NASDAQ: SBRA Reit - Healthcare Facilities
$20.35
▲ $0.63 (+3.19%) today
Markets closed · 1:59am ET

Sabra Health Care REIT (SBRA) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
57%
EPS beat rate
−6.45%
Avg. EPS surprise
Consecutive EPS beats
SBRA vs Market · 30-day return after each reportSBRAS&P 500
−10%−5%0%+5%−0.2%+7.2%Q1 25+4.7%+3.1%Q2 25+2.4%+1.9%Q3 25+2.3%−3.0%Q4 25−10.1%+5.7%Q1 26+1.3%+0.2%Q2 26
−10%−5%0%+5%Q1 25Q3 25Q1 26
SBRA EPS Trend · estimate vs actualEstimateActual
$0.00$0.20$0.40$0.17$0.17Q1 25$0.17$0.27Q2 25$0.18$0.09Q3 25$0.16$0.11Q4 25$0.16$0.16Q1 26$0.17$-0.10Q2 26$0.17$0.39Q3 26
$0.00$0.20$0.40Q1 25Q3 25Q1 26Q3 26
SBRA Revenue Trend · estimate vs actualEstimateActual
$0$70.0M$140.0M$210.0M$180.2M$183.5MQ1 25$182.8M$189.2MQ2 25$188.6M$190.0MQ3 25$202.0M$211.9MQ4 25$216.4M$221.8MQ1 26$219.5M$235.9MQ2 26$236.4M$249.6MQ3 26
$0$70.0M$140.0M$210.0MQ1 25Q3 25Q1 26Q3 26

How Often Does Sabra Health Care REIT Beat Earnings Estimates?

Sabra Health Care REIT beat EPS estimates in 4 of its last 7 reported quarters.

Includes a mix of GAAP and Adjusted data due to SBRA changing standards over time.

SBRA quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted Normalized FFO per diluted share ($0.39) excludes a $10.2 million deferred rent payment related to a triple-net lease. GAAP diluted EPS of $0.11 includes an $8,065 thousand net loss on sales of real estate, $6,200 thousand of write-offs of straight-line rental income receivable and lease intangibles, and a $2,368 thousand provision for loan losses and other reserves. $0.39 est. $0.17 +136.36% $249.6M est. $236.4M +5.58%
Q2 2026 $-0.10 est. $0.17 −159.99% $235.9M est. $219.5M +7.48%
Q1 2026 GAAP Includes $0.4 million real estate impairment charge in Q1 2026 $0.16 est. $0.16 +0.00% $221.8M est. $216.4M +2.46%
Q4 2025 $0.11 est. $0.16 −31.25% $211.9M est. $202.0M +4.92%
Q3 2025 $0.09 est. $0.18 −49.07% $190.0M est. $188.6M +0.74%
Q2 2025 $0.27 est. $0.17 +58.82% $189.2M est. $182.8M +3.48%
Q1 2025 $0.17 est. $0.17 +0.00% $183.5M est. $180.2M +1.84%

Figures from SEC filings and company reports. Not investment advice.